About India Glycols Limited
Data last updated: 02 July 2026
India Glycols Limited is a public limited company based in Udham Singh Nagar, Uttarakhand, India. It specialises in specialty chemicals, a part of the broader chemicals and materials sector. Incorporated on 19 November 1983, the company has been in operation for over 43 years.
Registered with ROC Uttarakhand under CIN L24111UR1983PLC009097. Listed on BSE: 500201 and NSE: INDIAGLYCO.
Capital: an authorised share capital of ₹45 Cr and a paid-up capital of ₹33.51 Cr. It is led by directors including Uma Shankar Bhartia and Pragya Bhartia Barwale.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 1 Industrial Area Bazpur Road Kashipur, Udham Singh Nagar, Uttarakhand, India – 244713.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹9,826.63 Cr, a growth of 8.71% compared to the previous year. The net worth stands at ₹2,932.78 Cr (up 30.01% YoY). Total assets are valued at ₹6,522.95 Cr (up 5.62% YoY).
The company has a workforce of approximately 1,347 employees as per the latest available data. Its group structure includes 3 subsidiaries and 1 joint venture.
The company is associated with 3 brands - Ennature Biopharma, Principle Circle, India Glycols. As per MCA filings, the company has open charges of ₹3,185.68 Cr and satisfied charges of ₹12,932 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indiaglycols.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressA – 1 Industrial Area Bazpur Road Kashipur, Udham Singh Nagar, Uttarakhand, India – 244713
-
IndustryChemicals and Materials, Specialty Chemicals, Industrial & Specialty Gases
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of India Glycols Limited
India Glycols Limited has one previous CIN (Corporate Identification Number): L24111UP1983PLC009097. The current CIN is L24111UR1983PLC009097, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24111UR1983PLC009097 | Current |
| L24111UP1983PLC009097 | Previous |
Associated Brands with India Glycols Limited
India Glycols Limited operates multiple associated brands including Ennature Biopharma, Principle Circle, and India Glycols. These brands represent India Glycols Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies pure nicotine, pharmaceutical actives, and nutraceutical ingredients globally. | ennaturebiopharma.com | |
| Offers management consulting and innovative products in education and entertainment sectors. | principlecircle.com | |
| Bulk, specialty, and performance chemicals are supplied to various industries. | indiaglycols.com |
Competitors & Alternatives of India Glycols Limited
Brands and companies operating in the same space as India Glycols Limited include TeamLease, Laurus Labs, Cyient and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Staffing and recruiting services connect employers with job candidates. | Bengaluru, India, India | 2000 |
|
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
|
|
Provider of digital engineering and technology services | Hyderabad, India, India | 1991 |
|
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
|
|
Advisory, consulting, technology, and analytics solutions are provided across industries. | Amman, Jordan, Jordan | 2002 |
|
|
Phytochemicals are developed using microbial fermentation processes. | Cambridge, United States, United States | 2011 |
|
|
Waste carbon is treated via a bio-processing platform. | Skokie, United States, United States | 2005 |
|
|
Provider of software development, cloud & data management, and IT consulting services | United States | 1994 |
|
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
|
|
Business consulting, activation, and transformation services are provided. | Navi Mumbai, India, India | 2006 |
Business Activity of India Glycols Limited
India Glycols Limited is engaged in principal business activities including manufacturing and trade, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, wholesale trading. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details for India Glycols Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of India Glycols Limited
India Glycols Limited is audited by M/s K N Gutgutia & Co. (ICAI peer reviewed, certificate valid till 2027-11-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s K N Gutgutia & Co. (ICAI peer reviewed, certificate valid till 2027-11-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors and KMP of India Glycols Limited
India Glycols Limited currently reports 8 directors and 3 key managerial personnel. 17 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Uma Shankar Bhartia
Also directs:
Pooja Jhaver Beneficiary Llp, Pragya Bhartia Barwale Beneficiary Llp, Jayshree Bhartia Beneficiary Llp and 5 more
|
Managing Director | 29 Nov 1996 | 29 Years 7 Months | Current |
|
Pragya Bhartia Barwale
Also directs:
Pragya Bhartia Barwale Beneficiary Llp, Lund And Blockley Pvt Ltd, Ajay Commercial Co Pvt Ltd and 5 more
|
Whole-Time Director | 24 Jun 2020 | 6 Years 0 Months | Current |
|
Rupark Chandi Sarswat
Also directs:
Clariant Igl Specialty Chemicals Private Limited
|
Ceo | 21 Dec 2020 | 5 Years 6 Months | Current |
|
Shukla Wassan
Also directs:
Kwality Wall's (India) Limited, Ge Power India Limited
|
Director | 01 Apr 2020 | 6 Years 3 Months | Current |
| Ankur Jain | Company Secretary | 02 Nov 2023 | 2 Years 8 Months | Current |
|
Jayshree Bhartia
Also directs:
Pooja Jhaver Beneficiary Llp, Pragya Bhartia Barwale Beneficiary Llp, Jayshree Bhartia Beneficiary Llp and 5 more
|
Director | 28 May 1999 | 27 Years 1 Months | Current |
Financials of India Glycols Limited FY 2026 filings available
India Glycols Limited reported revenue of ₹9,826.63 Cr (up 8.71% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹9,826.63 Cr | ₹9,038.95 Cr | ₹7,921.54 Cr | ₹6,641.64 Cr | ₹6,601.41 Cr | ₹5,427.47 Cr | ₹5,972.65 Cr |
| Other Income | ₹4.93 Cr | ₹14.55 Cr | ₹25.73 Cr | ₹23.89 Cr | ₹21.54 Cr | ₹15.26 Cr | ₹8.77 Cr |
| Total Income | ₹9,831.56 Cr | ₹9,053.5 Cr | ₹7,947.27 Cr | ₹6,665.53 Cr | ₹6,622.95 Cr | ₹5,442.73 Cr | ₹5,981.42 Cr |
| Cost of Materials Consumed | ₹2,412.43 Cr | ₹2,345.81 Cr | ₹1,818.92 Cr | ₹1,444.75 Cr | ₹1,666.94 Cr | ₹1,185.6 Cr | ₹1,685.7 Cr |
| Purchases of Stock-in-Trade | ₹187.22 Cr | ₹113.59 Cr | ₹321.8 Cr | ₹160.12 Cr | ₹351.37 Cr | ₹328.27 Cr | ₹630.89 Cr |
| Changes in Inventories | ₹62.35 Cr | -₹51.55 Cr | ₹8.11 Cr | -₹22.56 Cr | -₹96.89 Cr | -₹14.7 Cr | ₹11.62 Cr |
| Employee Benefit Expense | ₹132.61 Cr | ₹122.69 Cr | ₹103.37 Cr | ₹88.8 Cr | ₹89.16 Cr | ₹83.33 Cr | ₹114.38 Cr |
| Finance Costs | ₹167.18 Cr | ₹164.37 Cr | ₹120.67 Cr | ₹99.96 Cr | ₹69.66 Cr | ₹83.38 Cr | ₹143.41 Cr |
| Depreciation & Amortisation | ₹155.38 Cr | ₹115.2 Cr | ₹100.77 Cr | ₹93.96 Cr | ₹80.29 Cr | ₹80.12 Cr | ₹82.97 Cr |
| Other Expenses | ₹6,382.77 Cr | ₹5,997.47 Cr | ₹5,266.98 Cr | ₹4,675 Cr | ₹4,335.63 Cr | ₹3,576.97 Cr | ₹3,138.13 Cr |
| Total Expenses | ₹9,499.94 Cr | ₹8,807.58 Cr | ₹7,740.62 Cr | ₹6,540.03 Cr | ₹6,496.16 Cr | ₹5,322.97 Cr | ₹5,807.1 Cr |
| Profit Before Exceptional Items & Tax | ₹331.62 Cr | ₹245.92 Cr | ₹206.65 Cr | ₹125.5 Cr | ₹126.79 Cr | ₹119.76 Cr | ₹174.32 Cr |
| Exceptional Items | -₹83 Lakh | ₹0 | ₹0 | ₹28.13 Cr | ₹221.34 Cr | ₹0 | ₹0 |
| Profit Before Tax | ₹330.79 Cr | ₹245.92 Cr | ₹206.65 Cr | ₹153.63 Cr | ₹348.13 Cr | ₹119.76 Cr | ₹174.32 Cr |
| Total Tax Expense | ₹84.45 Cr | ₹61.4 Cr | ₹50.32 Cr | ₹23.96 Cr | ₹39.43 Cr | ₹11.28 Cr | ₹59.25 Cr |
| Net Profit | ₹292.76 Cr | ₹230.92 Cr | ₹172.99 Cr | ₹141.04 Cr | ₹339.85 Cr | ₹131.61 Cr | ₹114.66 Cr |
| attributable to Owners | ₹292.76 Cr | ₹230.92 Cr | ₹172.99 Cr | ₹125.08 Cr | ₹339.85 Cr | ₹131.61 Cr | ₹114.66 Cr |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹15.96 Cr | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹1.62 Cr | -₹1.3 Cr | -₹19 Lakh | ₹40 Lakh | -₹47 Lakh | ₹3.05 Cr | -₹1.36 Cr |
| Total Comprehensive Income | ₹291.14 Cr | ₹229.62 Cr | ₹172.8 Cr | ₹141.44 Cr | ₹339.38 Cr | ₹134.66 Cr | ₹113.3 Cr |
| EBITDA (computed) | ₹654.18 Cr | ₹525.49 Cr | ₹428.09 Cr | ₹319.42 Cr | ₹276.74 Cr | ₹283.26 Cr | ₹400.7 Cr |
| Basic EPS | ₹45.95 | ₹74.58 | ₹55.87 | ₹45.55 | ₹106.45 | ₹35.27 | ₹37.03 |
| Diluted EPS | ₹45.95 | ₹74.58 | ₹55.87 | ₹45.55 | ₹106.45 | ₹35.27 | ₹37.03 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹6,522.95 Cr | ₹6,176.1 Cr | ₹5,616.8 Cr | ₹4,858.33 Cr |
| Non-current Assets | ₹5,025.14 Cr | ₹4,359.88 Cr | ₹3,672.1 Cr | ₹3,212.09 Cr |
| Current Assets | ₹1,497.81 Cr | ₹1,816.22 Cr | ₹1,944.7 Cr | ₹1,646.24 Cr |
| Property, Plant & Equipment | ₹4,551.29 Cr | ₹3,825.95 Cr | ₹3,196.77 Cr | ₹2,707.37 Cr |
| Inventories | ₹890.61 Cr | ₹1,170.88 Cr | ₹1,106.29 Cr | ₹753.83 Cr |
| Trade Receivables | ₹351.4 Cr | ₹364.97 Cr | ₹384.1 Cr | ₹430.34 Cr |
| Cash & Equivalents | ₹31.87 Cr | ₹6.84 Cr | ₹26.96 Cr | ₹1.97 Cr |
| Equity (Net Worth) | ₹2,932.78 Cr | ₹2,255.88 Cr | ₹2,051.02 Cr | ₹1,901.42 Cr |
| Equity Share Capital | ₹33.51 Cr | ₹30.96 Cr | ₹30.96 Cr | ₹30.96 Cr |
| Borrowings (Non-current) | ₹919.13 Cr | ₹1,040.09 Cr | ₹725.08 Cr | ₹550.77 Cr |
| Borrowings (Current) | ₹659.34 Cr | ₹764.18 Cr | ₹596.03 Cr | ₹543.3 Cr |
| Total Debt (computed) | ₹1,578.47 Cr | ₹1,804.27 Cr | ₹1,321.11 Cr | ₹1,094.07 Cr |
| Current Liabilities | ₹2,014.11 Cr | ₹2,321.04 Cr | ₹2,374.73 Cr | ₹1,864.93 Cr |
| Total Liabilities | ₹3,590.17 Cr | ₹3,920.22 Cr | ₹3,565.78 Cr | ₹2,956.91 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹769.17 Cr | ₹362.11 Cr | ₹438.51 Cr | ₹325.71 Cr | ₹91.42 Cr |
| Investing Cash Flow | -₹766.68 Cr | -₹735.99 Cr | -₹503.45 Cr | -₹330.28 Cr | ₹93.13 Cr |
| Financing Cash Flow | ₹22.54 Cr | ₹353.76 Cr | ₹89.93 Cr | -₹51 Lakh | -₹180.89 Cr |
| Capital Expenditure | ₹823.48 Cr | ₹760.47 Cr | ₹552.93 Cr | ₹438.77 Cr | ₹379.92 Cr |
| Free Cash Flow (computed) | -₹54.31 Cr | -₹398.36 Cr | -₹114.42 Cr | -₹113.06 Cr | -₹288.5 Cr |
| Dividends Paid | ₹75.31 Cr | ₹24.59 Cr | ₹22.97 Cr | ₹23.04 Cr | ₹18.39 Cr |
| Net Change in Cash | ₹25.03 Cr | -₹20.12 Cr | ₹24.99 Cr | -₹5.08 Cr | ₹3.66 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹2,360.01 Cr | ₹2,551.1 Cr | ₹2,412.4 Cr | ₹2,503.12 Cr | ₹2,188.65 Cr | ₹2,424.01 Cr | ₹2,143.71 Cr | ₹2,282.58 Cr | ₹2,039.08 Cr | ₹2,118.94 Cr | ₹1,869.88 Cr | ₹1,893.64 Cr |
| Other Income | ₹62 Lakh | ₹74 Lakh | ₹2.17 Cr | ₹1.4 Cr | ₹1.59 Cr | ₹5.82 Cr | ₹4.34 Cr | ₹2.8 Cr | ₹4.65 Cr | ₹4.55 Cr | ₹10.73 Cr | ₹5.8 Cr |
| Total Income | ₹2,360.63 Cr | ₹2,551.84 Cr | ₹2,414.57 Cr | ₹2,504.52 Cr | ₹2,190.24 Cr | ₹2,429.83 Cr | ₹2,148.05 Cr | ₹2,285.38 Cr | ₹2,043.73 Cr | ₹2,123.49 Cr | ₹1,880.61 Cr | ₹1,899.44 Cr |
| Cost of Materials Consumed | ₹484.66 Cr | ₹597.82 Cr | ₹660.85 Cr | ₹669.1 Cr | ₹488.26 Cr | ₹642.29 Cr | ₹584.28 Cr | ₹630.98 Cr | ₹501.46 Cr | ₹515.96 Cr | ₹407.33 Cr | ₹394.17 Cr |
| Purchases of Stock-in-Trade | ₹38.79 Cr | ₹40.84 Cr | ₹63.25 Cr | ₹44.34 Cr | ₹32.27 Cr | ₹25.39 Cr | ₹34.48 Cr | ₹21.45 Cr | ₹115.69 Cr | ₹114.16 Cr | ₹88.06 Cr | ₹3.89 Cr |
| Changes in Inventories | ₹83.51 Cr | ₹53.06 Cr | -₹38.25 Cr | -₹35.97 Cr | ₹13.36 Cr | -₹45.67 Cr | ₹6 Cr | -₹25.24 Cr | ₹18.61 Cr | -₹12.55 Cr | ₹1.87 Cr | ₹18 Lakh |
| Employee Benefit Expense | ₹34.21 Cr | ₹35.23 Cr | ₹32.11 Cr | ₹31.06 Cr | ₹30.56 Cr | ₹31.2 Cr | ₹30.28 Cr | ₹30.65 Cr | ₹29.94 Cr | ₹27.44 Cr | ₹23.18 Cr | ₹22.81 Cr |
| Finance Costs | ₹26.41 Cr | ₹46.81 Cr | ₹49.28 Cr | ₹44.68 Cr | ₹44.53 Cr | ₹44.07 Cr | ₹39.91 Cr | ₹35.86 Cr | ₹32.63 Cr | ₹31.41 Cr | ₹29.05 Cr | ₹27.58 Cr |
| Depreciation & Amortisation | ₹41.23 Cr | ₹41.22 Cr | ₹38.48 Cr | ₹34.45 Cr | ₹32.59 Cr | ₹27.47 Cr | ₹27.57 Cr | ₹27.57 Cr | ₹26.04 Cr | ₹26.24 Cr | ₹27.96 Cr | ₹20.53 Cr |
| Other Expenses | ₹1,552.34 Cr | ₹1,648.68 Cr | ₹1,536.8 Cr | ₹1,644.95 Cr | ₹1,478.26 Cr | ₹1,647.14 Cr | ₹1,372.89 Cr | ₹1,499.18 Cr | ₹1,268.8 Cr | ₹1,371.67 Cr | ₹1,253.93 Cr | ₹1,372.58 Cr |
| Total Expenses | ₹2,261.15 Cr | ₹2,463.66 Cr | ₹2,342.52 Cr | ₹2,432.61 Cr | ₹2,119.83 Cr | ₹2,371.89 Cr | ₹2,095.41 Cr | ₹2,220.45 Cr | ₹1,993.17 Cr | ₹2,074.33 Cr | ₹1,831.38 Cr | ₹1,841.74 Cr |
| Profit Before Exceptional Items & Tax | ₹99.48 Cr | ₹88.18 Cr | ₹72.05 Cr | ₹71.91 Cr | ₹70.41 Cr | ₹57.94 Cr | ₹52.64 Cr | ₹64.93 Cr | ₹50.56 Cr | ₹49.16 Cr | ₹49.23 Cr | ₹57.7 Cr |
| Exceptional Items | ₹0 | -₹83 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹99.48 Cr | ₹87.35 Cr | ₹72.05 Cr | ₹71.91 Cr | ₹70.41 Cr | ₹57.94 Cr | ₹52.64 Cr | ₹64.93 Cr | ₹50.56 Cr | ₹49.16 Cr | ₹49.23 Cr | ₹57.7 Cr |
| Total Tax Expense | ₹25.58 Cr | ₹23.04 Cr | ₹18.55 Cr | ₹17.28 Cr | ₹17.77 Cr | ₹14.61 Cr | ₹13.75 Cr | ₹15.27 Cr | ₹13.39 Cr | ₹12.26 Cr | ₹12.09 Cr | ₹12.58 Cr |
| Net Profit | ₹86.88 Cr | ₹67.57 Cr | ₹65.06 Cr | ₹73.25 Cr | ₹64.02 Cr | ₹56.81 Cr | ₹49.71 Cr | ₹60.38 Cr | ₹42.21 Cr | ₹41.63 Cr | ₹38.01 Cr | ₹51.14 Cr |
| attributable to Owners | ₹86.88 Cr | - | ₹65.06 Cr | ₹73.25 Cr | ₹64.02 Cr | - | ₹49.71 Cr | ₹60.38 Cr | ₹42.21 Cr | ₹41.63 Cr | ₹38.01 Cr | ₹51.14 Cr |
| attributable to NCI | ₹0 | - | - | ₹0 | ₹0 | - | - | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹80 Lakh | -₹25 Lakh | -₹14 Lakh | -₹43 Lakh | -₹76 Lakh | -₹42 Lakh | -₹7 Lakh | -₹5 Lakh | -₹14 Lakh | ₹51 Lakh | -₹38 Lakh | -₹18 Lakh |
| Total Comprehensive Income | ₹86.08 Cr | ₹67.32 Cr | ₹64.92 Cr | ₹72.82 Cr | ₹63.26 Cr | ₹56.39 Cr | ₹49.64 Cr | ₹60.33 Cr | ₹42.07 Cr | ₹42.14 Cr | ₹37.63 Cr | ₹50.96 Cr |
| EBITDA (computed) | ₹167.12 Cr | ₹176.21 Cr | ₹159.81 Cr | ₹151.04 Cr | ₹147.53 Cr | ₹129.48 Cr | ₹120.12 Cr | ₹128.36 Cr | ₹109.23 Cr | ₹106.81 Cr | ₹106.24 Cr | ₹105.81 Cr |
| Basic EPS | ₹13.64 | ₹10.79 | ₹10.51 | ₹23.66 | ₹20.68 | ₹18.35 | ₹16.06 | ₹19.50 | ₹13.63 | ₹13.45 | ₹12.27 | ₹16.52 |
| Diluted EPS | ₹13.64 | ₹10.79 | ₹10.51 | ₹23.66 | ₹20.68 | ₹18.35 | ₹16.06 | ₹19.50 | ₹13.63 | ₹13.45 | ₹12.27 | ₹16.52 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Bio-based Specialities and Performance Chemicals | ₹301.16 Cr | ₹36.76 Cr | ₹3,600.59 Cr | ₹737.97 Cr |
| Potable Spirits | ₹1,690.09 Cr | ₹67.78 Cr | ₹596.6 Cr | ₹326.53 Cr |
| Ennature Biopharma | ₹63.49 Cr | ₹3.01 Cr | ₹426.42 Cr | ₹92.49 Cr |
| Bio-Fuel | ₹305.27 Cr | ₹30.21 Cr | ₹1,429.96 Cr | ₹92.27 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Bio-based Specialities and Performance Chemicals | ₹1,202.5 Cr | ₹140.95 Cr | - | - |
| Potable Spirits | ₹6,946.43 Cr | ₹284.93 Cr | - | - |
| Ennature Biopharma | ₹207.77 Cr | ₹7.23 Cr | - | - |
| Bio-Fuel | ₹1,469.93 Cr | ₹115.23 Cr | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹9,826.2 Cr | ₹9,037.82 Cr | ₹7,918.77 Cr | ₹6,640.86 Cr | ₹6,596.33 Cr | ₹5,390 Cr | ₹5,951.17 Cr |
| Other Income | ₹43.51 Cr | ₹14.55 Cr | ₹25.73 Cr | ₹27.59 Cr | ₹26.53 Cr | ₹12.08 Cr | ₹12.18 Cr |
| Total Income | ₹9,869.71 Cr | ₹9,052.37 Cr | ₹7,944.5 Cr | ₹6,668.45 Cr | ₹6,622.86 Cr | ₹5,402.08 Cr | ₹5,963.35 Cr |
| Cost of Materials Consumed | ₹2,412.43 Cr | ₹2,345.81 Cr | ₹1,818.92 Cr | ₹1,444.75 Cr | ₹1,666.94 Cr | ₹1,185.6 Cr | ₹1,685.7 Cr |
| Purchases of Stock-in-Trade | ₹188.46 Cr | ₹111.8 Cr | ₹319.68 Cr | ₹159.49 Cr | ₹350.36 Cr | ₹300.9 Cr | ₹610.87 Cr |
| Changes in Inventories | ₹60.92 Cr | -₹50.46 Cr | ₹7.66 Cr | -₹22.13 Cr | -₹96.89 Cr | -₹14.4 Cr | ₹11.36 Cr |
| Employee Benefit Expense | ₹130.69 Cr | ₹120.89 Cr | ₹101.62 Cr | ₹87.13 Cr | ₹87.59 Cr | ₹81.69 Cr | ₹112.48 Cr |
| Finance Costs | ₹167.18 Cr | ₹164.37 Cr | ₹120.67 Cr | ₹95.19 Cr | ₹62.17 Cr | ₹73.45 Cr | ₹136.76 Cr |
| Depreciation & Amortisation | ₹155.38 Cr | ₹115.19 Cr | ₹100.76 Cr | ₹89.65 Cr | ₹75.98 Cr | ₹75.81 Cr | ₹78.64 Cr |
| Other Expenses | ₹6,387.12 Cr | ₹6,002.99 Cr | ₹5,273.14 Cr | ₹4,674.1 Cr | ₹4,335.96 Cr | ₹3,578.71 Cr | ₹3,140.03 Cr |
| Total Expenses | ₹9,502.18 Cr | ₹8,810.59 Cr | ₹7,742.45 Cr | ₹6,528.18 Cr | ₹6,482.11 Cr | ₹5,281.76 Cr | ₹5,775.84 Cr |
| Profit Before Exceptional Items & Tax | ₹367.53 Cr | ₹241.78 Cr | ₹202.05 Cr | ₹140.27 Cr | ₹140.75 Cr | ₹120.32 Cr | ₹187.51 Cr |
| Exceptional Items | -₹83 Lakh | ₹0 | ₹0 | -₹17.57 Cr | ₹200.63 Cr | ₹0 | ₹0 |
| Profit Before Tax | ₹366.7 Cr | ₹241.78 Cr | ₹202.05 Cr | ₹122.7 Cr | ₹341.38 Cr | ₹120.32 Cr | ₹187.51 Cr |
| Total Tax Expense | ₹84.37 Cr | ₹61.4 Cr | ₹50.32 Cr | ₹23.96 Cr | ₹66.26 Cr | ₹58.43 Cr | ₹59.25 Cr |
| Net Profit | ₹282.33 Cr | ₹180.38 Cr | ₹151.73 Cr | ₹98.74 Cr | ₹285.39 Cr | ₹84.3 Cr | ₹128.26 Cr |
| Other Comprehensive Income | -₹1.7 Cr | -₹87 Lakh | ₹19 Lakh | ₹34 Lakh | -₹7 Lakh | ₹2.95 Cr | -₹11.37 Lakh |
| Total Comprehensive Income | ₹280.63 Cr | ₹179.51 Cr | ₹151.92 Cr | ₹99.08 Cr | ₹285.32 Cr | ₹87.25 Cr | ₹128.15 Cr |
| EBITDA (computed) | ₹690.09 Cr | ₹521.34 Cr | ₹423.48 Cr | ₹325.11 Cr | ₹278.9 Cr | ₹269.58 Cr | ₹402.91 Cr |
| Basic EPS | ₹44.31 | ₹58.26 | ₹49.01 | ₹31.89 | ₹88.86 | ₹19.99 | ₹41.43 |
| Diluted EPS | ₹44.31 | ₹58.26 | ₹49.01 | ₹31.89 | ₹88.86 | ₹19.99 | ₹41.43 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹6,126.12 Cr | ₹5,790.4 Cr | ₹5,281.12 Cr | ₹4,543.48 Cr |
| Non-current Assets | ₹4,636.39 Cr | ₹3,978.61 Cr | ₹3,336.98 Cr | ₹2,895.18 Cr |
| Current Assets | ₹1,489.73 Cr | ₹1,811.79 Cr | ₹1,944.14 Cr | ₹1,648.3 Cr |
| Property, Plant & Equipment | ₹4,551.29 Cr | ₹3,825.95 Cr | ₹3,196.76 Cr | ₹2,707.36 Cr |
| Inventories | ₹887.99 Cr | ₹1,168.8 Cr | ₹1,103.7 Cr | ₹753.05 Cr |
| Trade Receivables | ₹352.66 Cr | ₹366.04 Cr | ₹389.45 Cr | ₹436.26 Cr |
| Cash & Equivalents | ₹31.06 Cr | ₹6.51 Cr | ₹26.75 Cr | ₹1.81 Cr |
| Equity (Net Worth) | ₹2,537.44 Cr | ₹1,871.04 Cr | ₹1,716.3 Cr | ₹1,587.61 Cr |
| Equity Share Capital | ₹33.51 Cr | ₹30.96 Cr | ₹30.96 Cr | ₹30.96 Cr |
| Borrowings (Non-current) | ₹919.13 Cr | ₹1,040.09 Cr | ₹725.08 Cr | ₹550.77 Cr |
| Borrowings (Current) | ₹659.34 Cr | ₹764.18 Cr | ₹596.03 Cr | ₹543.3 Cr |
| Total Debt (computed) | ₹1,578.47 Cr | ₹1,804.27 Cr | ₹1,321.11 Cr | ₹1,094.07 Cr |
| Current Liabilities | ₹2,012.62 Cr | ₹2,320.18 Cr | ₹2,373.77 Cr | ₹1,863.89 Cr |
| Total Liabilities | ₹3,588.68 Cr | ₹3,919.36 Cr | ₹3,564.82 Cr | ₹2,955.87 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹768.99 Cr | ₹361.99 Cr | ₹438.46 Cr | ₹325.91 Cr | ₹89.75 Cr |
| Investing Cash Flow | -₹766.98 Cr | -₹735.99 Cr | -₹503.45 Cr | -₹330.32 Cr | ₹93.48 Cr |
| Financing Cash Flow | ₹22.54 Cr | ₹353.76 Cr | ₹89.93 Cr | -₹42 Lakh | -₹179.59 Cr |
| Capital Expenditure | -₹6.86 Cr | -₹7.71 Cr | -₹10.92 Cr | -₹4.11 Cr | ₹379.92 Cr |
| Free Cash Flow (computed) | ₹762.13 Cr | ₹354.28 Cr | ₹427.54 Cr | ₹321.8 Cr | -₹290.17 Cr |
| Dividends Paid | ₹75.31 Cr | ₹24.59 Cr | ₹22.97 Cr | ₹23.04 Cr | ₹18.39 Cr |
| Net Change in Cash | ₹24.55 Cr | -₹20.24 Cr | ₹24.94 Cr | -₹4.83 Cr | ₹3.64 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹2,361.4 Cr | ₹2,551.06 Cr | ₹2,410.71 Cr | ₹2,503.03 Cr | ₹2,188 Cr | ₹2,423.76 Cr | ₹2,143.63 Cr | ₹2,282.43 Cr | ₹2,036.57 Cr | ₹2,119.19 Cr | ₹1,870.64 Cr | ₹1,892.37 Cr |
| Other Income | ₹39.2 Cr | ₹74 Lakh | ₹2.17 Cr | ₹1.4 Cr | ₹1.59 Cr | ₹5.82 Cr | ₹4.34 Cr | ₹2.8 Cr | ₹4.65 Cr | ₹4.55 Cr | ₹10.73 Cr | ₹5.8 Cr |
| Total Income | ₹2,400.6 Cr | ₹2,551.8 Cr | ₹2,412.88 Cr | ₹2,504.43 Cr | ₹2,189.59 Cr | ₹2,429.58 Cr | ₹2,147.97 Cr | ₹2,285.23 Cr | ₹2,041.22 Cr | ₹2,123.74 Cr | ₹1,881.37 Cr | ₹1,898.17 Cr |
| Cost of Materials Consumed | ₹484.66 Cr | ₹597.82 Cr | ₹660.85 Cr | ₹669.1 Cr | ₹488.26 Cr | ₹642.29 Cr | ₹584.28 Cr | ₹630.98 Cr | ₹501.46 Cr | ₹515.96 Cr | ₹407.33 Cr | ₹394.17 Cr |
| Purchases of Stock-in-Trade | ₹40.25 Cr | ₹40.81 Cr | ₹63.21 Cr | ₹44.19 Cr | ₹30.59 Cr | ₹25.34 Cr | ₹34.48 Cr | ₹21.39 Cr | ₹113.35 Cr | ₹114.11 Cr | ₹91 Cr | ₹1.22 Cr |
| Changes in Inventories | ₹83.51 Cr | ₹53.07 Cr | -₹39.69 Cr | -₹35.97 Cr | ₹14.44 Cr | -₹45.66 Cr | ₹6 Cr | -₹25.24 Cr | ₹18.61 Cr | -₹12.56 Cr | ₹22 Lakh | ₹1.39 Cr |
| Employee Benefit Expense | ₹33.68 Cr | ₹34.77 Cr | ₹31.64 Cr | ₹30.6 Cr | ₹30.1 Cr | ₹30.76 Cr | ₹29.82 Cr | ₹30.21 Cr | ₹29.5 Cr | ₹27.01 Cr | ₹22.74 Cr | ₹22.37 Cr |
| Finance Costs | ₹26.41 Cr | ₹46.81 Cr | ₹49.28 Cr | ₹44.68 Cr | ₹44.53 Cr | ₹44.07 Cr | ₹39.91 Cr | ₹35.86 Cr | ₹32.63 Cr | ₹31.41 Cr | ₹29.05 Cr | ₹27.58 Cr |
| Depreciation & Amortisation | ₹41.23 Cr | ₹41.22 Cr | ₹38.48 Cr | ₹34.45 Cr | ₹32.59 Cr | ₹27.46 Cr | ₹27.58 Cr | ₹27.56 Cr | ₹26.03 Cr | ₹26.25 Cr | ₹27.95 Cr | ₹20.53 Cr |
| Other Expenses | ₹1,555.08 Cr | ₹1,648.17 Cr | ₹1,536.62 Cr | ₹1,647.25 Cr | ₹1,480.96 Cr | ₹1,646.87 Cr | ₹1,372.7 Cr | ₹1,502.46 Cr | ₹1,268.51 Cr | ₹1,371.51 Cr | ₹1,255.32 Cr | ₹1,377.8 Cr |
| Total Expenses | ₹2,264.82 Cr | ₹2,462.67 Cr | ₹2,340.39 Cr | ₹2,434.3 Cr | ₹2,121.47 Cr | ₹2,371.13 Cr | ₹2,094.77 Cr | ₹2,223.22 Cr | ₹1,990.09 Cr | ₹2,073.69 Cr | ₹1,833.61 Cr | ₹1,845.06 Cr |
| Profit Before Exceptional Items & Tax | ₹135.78 Cr | ₹89.13 Cr | ₹72.49 Cr | ₹70.13 Cr | ₹68.12 Cr | ₹58.45 Cr | ₹53.2 Cr | ₹62.01 Cr | ₹51.13 Cr | ₹50.05 Cr | ₹47.76 Cr | ₹53.11 Cr |
| Exceptional Items | ₹0 | -₹83 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹135.78 Cr | ₹88.3 Cr | ₹72.49 Cr | ₹70.13 Cr | ₹68.12 Cr | ₹58.45 Cr | ₹53.2 Cr | ₹62.01 Cr | ₹51.13 Cr | ₹50.05 Cr | ₹47.76 Cr | ₹53.11 Cr |
| Total Tax Expense | ₹25.5 Cr | ₹23.04 Cr | ₹18.55 Cr | ₹17.28 Cr | ₹17.77 Cr | ₹14.61 Cr | ₹13.75 Cr | ₹15.27 Cr | ₹13.39 Cr | ₹12.26 Cr | ₹12.09 Cr | ₹12.58 Cr |
| Net Profit | ₹110.28 Cr | ₹65.26 Cr | ₹53.94 Cr | ₹52.85 Cr | ₹50.35 Cr | ₹43.84 Cr | ₹39.45 Cr | ₹46.74 Cr | ₹37.74 Cr | ₹37.79 Cr | ₹35.67 Cr | ₹40.53 Cr |
| Other Comprehensive Income | -₹1.14 Cr | -₹19 Lakh | -₹18 Lakh | -₹19 Lakh | -₹98 Lakh | ₹4 Lakh | ₹3 Lakh | ₹4 Lakh | ₹8 Lakh | ₹4 Lakh | ₹4 Lakh | ₹3 Lakh |
| Total Comprehensive Income | ₹109.14 Cr | ₹65.07 Cr | ₹53.76 Cr | ₹52.66 Cr | ₹49.37 Cr | ₹43.88 Cr | ₹39.48 Cr | ₹46.78 Cr | ₹37.82 Cr | ₹37.83 Cr | ₹35.71 Cr | ₹40.56 Cr |
| EBITDA (computed) | ₹203.42 Cr | ₹177.16 Cr | ₹160.25 Cr | ₹149.26 Cr | ₹145.24 Cr | ₹129.98 Cr | ₹120.69 Cr | ₹125.43 Cr | ₹109.79 Cr | ₹107.71 Cr | ₹104.76 Cr | ₹101.22 Cr |
| Basic EPS | ₹17.31 | ₹10.42 | ₹8.71 | ₹17.07 | ₹16.26 | ₹14.16 | ₹12.74 | ₹15.10 | ₹12.19 | ₹12.21 | ₹11.52 | ₹13.09 |
| Diluted EPS | ₹17.31 | ₹10.42 | ₹8.71 | ₹17.07 | ₹16.26 | ₹14.16 | ₹12.74 | ₹15.10 | ₹12.19 | ₹12.21 | ₹11.52 | ₹13.09 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Bio-based Specialities and Performance Chemicals | ₹302.55 Cr | ₹34.47 Cr | ₹3,595.99 Cr | ₹737.05 Cr |
| Potable Spirits | ₹1,690.09 Cr | ₹67.78 Cr | ₹596.6 Cr | ₹326.53 Cr |
| Ennature Biopharma | ₹63.49 Cr | ₹3.01 Cr | ₹426.42 Cr | ₹92.49 Cr |
| Bio-Fuel | ₹305.27 Cr | ₹30.21 Cr | ₹1,429.96 Cr | ₹92.27 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Bio-based Specialities and Performance Chemicals | ₹1,202.07 Cr | ₹138.27 Cr | - | - |
| Potable Spirits | ₹6,946.43 Cr | ₹284.93 Cr | - | - |
| Ennature Biopharma | ₹207.77 Cr | ₹7.23 Cr | - | - |
| Bio-Fuel | ₹1,469.93 Cr | ₹115.23 Cr | - | - |
Shareholding Pattern of India Glycols Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 59.63%, foreign institutional investors hold 2.27%, domestic institutional investors hold 5.20%, retail and other public shareholders hold 32.90% of India Glycols Limited. The company had 52,848 shareholders on record.
| Mar 2026 | Dec 2025 | Nov 2025 | Sep 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Promoters | 59.63% | 59.63% | 59.63% | 61.01% | 61.01% | 61.01% |
| Public | 40.37% | 40.37% | 40.37% | 38.99% | 38.99% | 38.99% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 59.63% | 61.01% | 61.01% | 61.01% | 61.02% | 61.02% | 61.02% | 61.01% | 61.01% | 61.07% | 61.07% |
| Public | 40.37% | 38.99% | 38.99% | 38.99% | 39.00% | 38.98% | 38.99% | 38.99% | 38.99% | 38.93% | 38.93% |
| Promoter change (YoY, %pts) | -1.38 | +0.00 | +0.00 | -0.01 | +0.00 | +0.00 | +0.01 | +0.00 | -0.06 | +0.00 | - |
Board & Governance of India Glycols Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of India Glycols Limited has 8 directors - 4 independent and 3 executive. The board is chaired by UMA SHANKAR BHARTIA.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| UMA SHANKAR BHARTIA | Executive Director · MD · Chairperson | 1996-11-29 | 2 |
| JAYSHREE BHARTIA | Non-Executive - Non Independent Director | 1999-05-28 | 1 |
| SHUKLA WASSAN | Non-Executive - Independent Director | 2020-04-01 | 3 |
| PRAGYA BHARTIA BARWALE | Executive Director | 2020-06-24 | 2 |
| ALOK SINGHAL | Executive Director | 2023-12-01 | 1 |
| RAVI KUMAR | Non-Executive - Independent Director | 2024-02-02 | 3 |
| SAMRAT BANERJEE | Non-Executive - Independent Director | 2024-10-01 | 1 |
| SUSHIL DUTT SALWAN | Non-Executive - Independent Director | 2024-10-01 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | RAVI KUMAR (Chairperson), SAMRAT BANERJEE, ALOK SINGHAL |
| Nomination and remuneration committee | RAVI KUMAR (Chairperson), SHUKLA WASSAN, SUSHIL DUTT SALWAN |
| Stakeholders Relationship Committee | SHUKLA WASSAN (Chairperson), SAMRAT BANERJEE, UMA SHANKAR BHARTIA |
| Risk Management Committee | UMA SHANKAR BHARTIA (Chairperson), PRAGYA BHARTIA BARWALE, RAVI KUMAR, SHUKLA WASSAN, ALOK SINGHAL, RUPARK SARSWAT, ANAND SINGHAL, ATUL GOVIL |
| Corporate Social Responsibility Committee | UMA SHANKAR BHARTIA (Chairperson), PRAGYA BHARTIA BARWALE, SAMRAT BANERJEE, ALOK SINGHAL |
Group Structure of India Glycols Limited
India Glycols Limited has 3 subsidiary companies, 1 joint venture, and 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects India Glycols Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Igl Chemicals And Services Private Limited | U24200UR2021PTC012141 | - |
| Ennature Bio Pharma Private Limited | U24290UR2021PTC013005 | - |
| Igl Finance Limited | U65922UR1997PLC022992 | - |
Showing major subsidiaries. Total: 3.
Charges & Borrowings of India Glycols Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 May 2026 | Others | ₹25 Cr | Open |
| 11 Mar 2026 | Others | ₹16 Lakh | Open |
| 11 Mar 2026 | Others | ₹18 Lakh | Open |
| 06 Feb 2026 | Others | ₹28 Lakh | Open |
| 22 Jan 2026 | Others | ₹157 Cr | Open |
Total charge records: 214 View all charges
Employees and EPFO Compliance at India Glycols Limited
India Glycols Limited has a workforce of 1,347 employees as of Mar 26, 2024.
Employee and EPFO history for India Glycols Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of India Glycols Limited
GST registrations and filing compliance for India Glycols Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for India Glycols Limited
Credit ratings, litigation, and regulatory alerts for India Glycols Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by India Glycols Limited
MSME payment history for India Glycols Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of India Glycols Limited
Corporate group structure for India Glycols Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of India Glycols Limited
MCA filings and documents for India Glycols Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on India Glycols Limited
Recent News on India Glycols Limited
Frequently Asked Questions about India Glycols Limited
India Glycols Limited is an active public limited company in the chemicals and materials sector based in Udham Singh Nagar, Uttarakhand, India. It was incorporated on 19 November 1983 (43+ years old) and is registered under CIN L24111UR1983PLC009097. Listed on BSE: 500201 and NSE: INDIAGLYCO. The company has 1,347 employees.
India Glycols Limited reported revenue of ₹9,826.63 Cr for FY 2026 (up 8.71% YoY) based on consolidated NSE filings.
The current directors and KMP of India Glycols Limited are:
- Uma Shankar Bhartia - Managing Director
- Pragya Bhartia Barwale - Whole-Time Director
- Rupark Chandi Sarswat - Ceo
- Shukla Wassan - Director
- Ankur Jain - Company Secretary
- Jayshree Bhartia - Director
- Anand Kumar Singhal - Cfo
- Samrat Banerjee - Director
- Sushil Dutt Salwan - Director
- Alok Singhal - Whole-Time Director
- Ravi Kumar - Director
The primary industry of India Glycols Limited is chemicals and materials. The company specifically operates in specialty chemicals. The company is currently active in this sector.
Yes. India Glycols Limited is listed on both BSE (code: 500201) and NSE (symbol: INDIAGLYCO).
India Glycols Limited can be reached at the registered office: A – 1 Industrial Area Bazpur Road Kashipur, Udham Singh Nagar, Uttarakhand, India – 244713, or through the website indiaglycols.com.